The firms will work collaboratively to develop an injection system for the delivery of Sensorion’s gene therapy products for the inner ear. EVEON, a company that designs and builds custom devices for preparation and administration of advanced therapeutic treatments, has partnered with Sensorion, a biotech firm that focuses on the development of therapies to treat, prevent, and restore hearing loss disorders. Together, they aim to design and advance an injection system to deliver Sensorion’s gene therapies to the inner ear,…

Andelyn Biosciences will produce Odylia Therapeutics’ gene therapy, OT-004, which aims to treat vision loss caused by the RPGRIP1 gene. Contract development manufacturing organization (CDMO) Andelyn has partnered with nonprofit biotech firm Odylia to produce OT-004, which is an investigational adeno-associated virus (AAV) that uses the ancestral AAV, Anc80 to create an efficient gene transfer of RPGRIP1 to treat vision loss in individuals that lack a functional copy of the gene. “Andelyn’s adherent production platforms utilize a transient transfection of…